These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 11120938

  • 1. Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint.
    Drusano GL, Preston SL, Hardalo C, Hare R, Banfield C, Andes D, Vesga O, Craig WA.
    Antimicrob Agents Chemother; 2001 Jan; 45(1):13-22. PubMed ID: 11120938
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1665-70. PubMed ID: 12019073
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3935-41. PubMed ID: 14638504
    [Abstract] [Full Text] [Related]

  • 4. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ, Seiler P, Surivet JP, Ritz D, Kohl C, Andes DR.
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models.
    Bulik CC, Okusanya ÓO, Lakota EA, Forrest A, Bhavnani SM, Hoover JL, Andes DR, Ambrose PG.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872075
    [Abstract] [Full Text] [Related]

  • 6. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ, Andes DR.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
    Hegde SS, Okusanya OO, Skinner R, Shaw JP, Obedencio G, Ambrose PG, Blais J, Bhavnani SM.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835
    [Abstract] [Full Text] [Related]

  • 8. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.
    Stass H, Dalhoff A.
    Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709
    [Abstract] [Full Text] [Related]

  • 9. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
    Lepak AJ, Marchillo K, Craig WA, Andes DR.
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
    [Abstract] [Full Text] [Related]

  • 10. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
    Craig WA, Andes DR.
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3492-6. PubMed ID: 18676887
    [Abstract] [Full Text] [Related]

  • 11. In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model.
    Andes D, Craig W, Nielsen LA, Kristensen HH.
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3003-9. PubMed ID: 19414576
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [Abstract] [Full Text] [Related]

  • 13. In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.
    Lepak AJ, Zhao M, Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559140
    [Abstract] [Full Text] [Related]

  • 15. In vivo pharmacodynamic activity of daptomycin.
    Safdar N, Andes D, Craig WA.
    Antimicrob Agents Chemother; 2004 Jan; 48(1):63-8. PubMed ID: 14693519
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):243-9. PubMed ID: 16377693
    [Abstract] [Full Text] [Related]

  • 17. In vivo pharmacodynamics of a new oxazolidinone (linezolid).
    Andes D, van Ogtrop ML, Peng J, Craig WA.
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Crandon JL, Banevicius MA, Nicolau DP.
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.